Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (2165)	7/14/1999 3:08:00 PM
From: Don Westermeyer	Respond to of 10293

OT - Interesting Asensio article: worth.com Bill, I know some have you pegged as being Asensio - the article contains your apparent background. :)

To: Bill Wexler who wrote (2165)	7/14/1999 3:13:00 PM
From: Bill Wexler	Read Replies (3) \| Respond to of 10293

Details of REFR's misleading stock promotions: Part I On July 28, 1997. REFR issued the following press release regarding the debut of their Suspended particle Device (SPD) technology at the SPIE show in San Diego (link to their web site): refr-spd.com In the fourth paragraph, a Dr. Carl Lampert is quoted as saying, "This represents one of the most innovative developments for the glass industry in the past twenty years..." implying that he was referring to REFR's SPD technology. At best this is misleading. We recently got in touch with Dr. Lampert and he stated that he was not referring to SPD at all but to "smart windows" in general. The quote was taken deliberately out of context to give the impression that this was somehow an endorsement of SPD. In fact, no such endorsement was made. Dr. Lampert is a former scientist with the Lawrence Berkely Natinal lab. Dr. Lampert did extensive research on electrochromic devices. Electrochromic technology is currently employed in numerous applications such as self-dimming rear-view mirrors and has gained wide commercial acceptance. In its entire 35-year history, Research Frontiers has failed to commercialize a single product.